0
0
Read Time:10 Second
Aurobindo Pharma subsidiary Eugia Pharma Specialities has received U.S. FDA’s final approval to manufacture and market Budesonide Inhalation Suspension, 0.5 mg/2 mL singledose ampule. Bioequivalent and therapeutically equivalent to Astrazeneca…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %